M

Mega Lifesciences PCL
SET:MEGA

Watchlist Manager
Mega Lifesciences PCL
SET:MEGA
Watchlist
Price: 37 THB 1.37% Market Closed
Market Cap: 32.3B THB
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-6%
5Y
+16%
10Y
+82%
Operating Income
+
3Y
+17%
5Y
+89%
10Y
+349%
Net Income
+
3Y
-16%
5Y
+47%
10Y
+192%

Earnings Waterfall
Mega Lifesciences PCL

Revenue
14.1B THB
Cost of Revenue
-6.8B THB
Gross Profit
7.4B THB
Operating Expenses
-4.3B THB
Operating Income
3B THB
Other Expenses
-1.1B THB
Net Income
2B THB

Income Statement
Mega Lifesciences PCL

Rotate your device to view
Income Statement
Currency: THB
Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
26
27
30
31
29
26
21
17
15
14
13
13
13
15
18
22
26
28
27
26
24
24
28
34
42
53
61
65
74
75
75
72
60
48
37
28
24
24
25
29
32
35
35
31
27
27
29
38
42
0
0
Revenue
6 179
N/A
6 536
+6%
6 776
+4%
7 034
+4%
7 209
+2%
7 404
+3%
7 601
+3%
7 730
+2%
7 830
+1%
7 843
+0%
7 755
-1%
7 945
+2%
8 097
+2%
8 207
+1%
8 497
+4%
8 810
+4%
8 949
+2%
9 263
+4%
9 494
+2%
9 597
+1%
9 749
+2%
9 904
+2%
10 132
+2%
10 342
+2%
10 641
+3%
10 734
+1%
10 947
+2%
11 130
+2%
11 621
+4%
11 611
0%
12 143
+5%
12 589
+4%
12 783
+2%
13 744
+8%
14 361
+4%
14 136
-2%
14 685
+4%
15 020
+2%
15 074
+0%
15 686
+4%
15 595
-1%
15 657
+0%
15 408
-2%
15 681
+2%
15 686
+0%
15 647
0%
15 845
+1%
15 344
-3%
14 819
-3%
14 265
-4%
14 140
-1%
Gross Profit
Cost of Revenue
(3 519)
(3 728)
(3 884)
(4 074)
(4 230)
(4 429)
(4 595)
(4 613)
(4 634)
(4 544)
(4 429)
(4 538)
(4 665)
(4 714)
(4 916)
(5 123)
(5 132)
(5 283)
(5 330)
(5 277)
(5 322)
(5 418)
(5 626)
(5 751)
(5 998)
(6 155)
(6 311)
(6 551)
(6 954)
(6 966)
(7 358)
(7 603)
(7 716)
(8 223)
(8 406)
(8 225)
(8 320)
(8 488)
(8 410)
(8 647)
(8 639)
(8 551)
(8 427)
(8 586)
(8 468)
(8 338)
(8 140)
(7 590)
(7 140)
(6 772)
(6 755)
Gross Profit
2 660
N/A
2 808
+6%
2 892
+3%
2 959
+2%
2 979
+1%
2 975
0%
3 006
+1%
3 117
+4%
3 196
+3%
3 299
+3%
3 326
+1%
3 406
+2%
3 432
+1%
3 493
+2%
3 581
+3%
3 687
+3%
3 817
+4%
3 980
+4%
4 165
+5%
4 320
+4%
4 427
+2%
4 485
+1%
4 506
+0%
4 591
+2%
4 643
+1%
4 579
-1%
4 636
+1%
4 578
-1%
4 667
+2%
4 644
0%
4 785
+3%
4 986
+4%
5 067
+2%
5 520
+9%
5 955
+8%
5 911
-1%
6 365
+8%
6 533
+3%
6 664
+2%
7 040
+6%
6 956
-1%
7 106
+2%
6 981
-2%
7 095
+2%
7 218
+2%
7 309
+1%
7 705
+5%
7 754
+1%
7 679
-1%
7 493
-2%
7 385
-1%
Operating Income
Operating Expenses
(2 028)
(2 110)
(2 155)
(2 213)
(2 285)
(2 349)
(2 442)
(2 463)
(2 474)
(2 564)
(2 648)
(2 696)
(2 696)
(2 639)
(2 585)
(2 656)
(2 747)
(2 850)
(2 908)
(2 965)
(2 908)
(2 973)
(3 048)
(3 243)
(3 219)
(3 223)
(3 217)
(3 176)
(3 183)
(3 123)
(3 167)
(3 299)
(3 342)
(3 550)
(3 779)
(3 769)
(3 924)
(4 054)
(4 068)
(4 318)
(4 398)
(4 352)
(4 278)
(4 157)
(4 230)
(4 331)
(4 402)
(4 343)
(4 355)
(4 336)
(4 336)
Selling, General & Administrative
(2 086)
(2 166)
(2 190)
(2 197)
(2 304)
(2 369)
(2 463)
(2 432)
(2 497)
(2 584)
(2 670)
(2 660)
(2 714)
(2 658)
(2 603)
(2 584)
(2 766)
(2 869)
(2 929)
(2 879)
(2 988)
(3 056)
(3 158)
(3 155)
(3 268)
(3 272)
(3 246)
(3 100)
(3 204)
(3 136)
(3 167)
(3 166)
(3 342)
(3 550)
(3 779)
(3 615)
(3 924)
(4 054)
(4 068)
(4 199)
(4 398)
(4 352)
(4 278)
(4 034)
(4 230)
(4 331)
(4 410)
(4 222)
(4 382)
(4 383)
(4 386)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(33)
0
0
0
(30)
0
0
0
(29)
0
0
0
(27)
0
0
0
(27)
0
0
0
(41)
0
0
0
(44)
0
0
0
(41)
0
0
0
(44)
0
0
0
Depreciation & Amortization
0
0
0
(39)
0
0
0
(51)
0
0
0
(58)
0
0
0
(57)
0
0
0
(56)
0
0
0
(58)
0
0
0
(49)
0
0
0
(106)
0
0
0
(114)
0
0
0
(115)
0
0
0
(116)
0
0
0
(119)
0
0
0
Other Operating Expenses
59
56
36
23
18
20
21
20
23
21
22
22
18
20
18
18
19
19
20
0
80
83
110
0
48
48
29
0
21
13
0
0
0
0
0
0
0
0
0
41
0
0
0
34
0
0
8
41
26
47
50
Operating Income
632
N/A
697
+10%
737
+6%
747
+1%
694
-7%
626
-10%
564
-10%
654
+16%
722
+10%
735
+2%
679
-8%
711
+5%
737
+4%
855
+16%
996
+17%
1 031
+3%
1 070
+4%
1 130
+6%
1 256
+11%
1 356
+8%
1 519
+12%
1 513
0%
1 458
-4%
1 348
-8%
1 424
+6%
1 356
-5%
1 419
+5%
1 402
-1%
1 484
+6%
1 521
+3%
1 618
+6%
1 687
+4%
1 724
+2%
1 971
+14%
2 176
+10%
2 141
-2%
2 441
+14%
2 479
+2%
2 596
+5%
2 722
+5%
2 558
-6%
2 754
+8%
2 703
-2%
2 939
+9%
2 988
+2%
2 978
0%
3 303
+11%
3 411
+3%
3 324
-3%
3 157
-5%
3 049
-3%
Pre-Tax Income
Interest Income Expense
(20)
(11)
(12)
11
0
(9)
(4)
(16)
(18)
22
122
117
114
40
(83)
(98)
(49)
(34)
(68)
(84)
(148)
(136)
(64)
(41)
(29)
(52)
(96)
(137)
(111)
(66)
(93)
(88)
(109)
(93)
38
99
112
112
36
(127)
(193)
(447)
(539)
(677)
(737)
(696)
(1 190)
(1 059)
(1 000)
(918)
(642)
Total Other Income
(0)
0
0
(1)
0
(0)
(0)
0
(0)
0
0
0
0
0
0
0
0
0
0
27
0
0
(0)
102
0
0
0
34
13
18
25
24
26
31
34
37
39
41
42
0
39
36
34
0
33
37
29
0
13
0
0
Pre-Tax Income
612
N/A
686
+12%
726
+6%
757
+4%
694
-8%
617
-11%
559
-9%
638
+14%
703
+10%
757
+8%
801
+6%
828
+3%
850
+3%
895
+5%
913
+2%
933
+2%
1 021
+9%
1 097
+7%
1 188
+8%
1 299
+9%
1 371
+6%
1 377
+0%
1 393
+1%
1 409
+1%
1 395
-1%
1 303
-7%
1 323
+1%
1 299
-2%
1 386
+7%
1 474
+6%
1 549
+5%
1 623
+5%
1 642
+1%
1 909
+16%
2 248
+18%
2 277
+1%
2 592
+14%
2 632
+2%
2 675
+2%
2 595
-3%
2 404
-7%
2 343
-3%
2 198
-6%
2 262
+3%
2 284
+1%
2 319
+2%
2 142
-8%
2 352
+10%
2 337
-1%
2 239
-4%
2 407
+7%
Net Income
Tax Provision
(100)
(117)
(131)
(133)
(128)
(102)
(87)
(90)
(105)
(123)
(125)
(132)
(147)
(139)
(142)
(138)
(149)
(152)
(165)
(186)
(193)
(202)
(210)
(203)
(192)
(168)
(159)
(160)
(180)
(188)
(204)
(234)
(242)
(307)
(377)
(336)
(371)
(345)
(340)
(355)
(324)
(301)
(279)
(269)
(267)
(320)
(295)
(340)
(352)
(377)
(433)
Income from Continuing Operations
512
570
595
624
567
515
473
548
598
634
675
696
703
756
771
795
873
945
1 023
1 113
1 178
1 175
1 183
1 206
1 203
1 136
1 164
1 139
1 206
1 286
1 345
1 388
1 400
1 602
1 872
1 941
2 221
2 288
2 335
2 240
2 080
2 042
1 919
1 993
2 017
1 999
1 846
2 013
1 985
1 863
1 974
Income to Minority Interest
(2)
(2)
(2)
0
1
1
2
0
0
0
0
0
(0)
(0)
(0)
(0)
0
0
0
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
(1)
2
2
4
6
5
6
6
6
5
3
1
0
0
0
0
0
0
(0)
(0)
(0)
(0)
0
Net Income (Common)
511
N/A
568
+11%
593
+4%
624
+5%
567
-9%
516
-9%
474
-8%
548
+16%
598
+9%
634
+6%
675
+6%
696
+3%
703
+1%
756
+7%
771
+2%
795
+3%
873
+10%
945
+8%
1 023
+8%
1 113
+9%
1 178
+6%
1 175
0%
1 183
+1%
1 206
+2%
1 203
0%
1 136
-6%
1 163
+2%
1 139
-2%
1 205
+6%
1 288
+7%
1 348
+5%
1 393
+3%
1 406
+1%
1 607
+14%
1 878
+17%
1 947
+4%
2 227
+14%
2 292
+3%
2 338
+2%
2 242
-4%
2 081
-7%
2 042
-2%
1 919
-6%
1 993
+4%
2 017
+1%
1 999
-1%
1 846
-8%
2 012
+9%
1 985
-1%
1 863
-6%
1 974
+6%
EPS (Diluted)
0.71
N/A
0.79
+11%
0.82
+4%
0.84
+2%
0.65
-23%
0.59
-9%
0.54
-8%
0.63
+17%
0.69
+10%
0.73
+6%
0.78
+7%
0.8
+3%
0.81
+1%
0.87
+7%
0.88
+1%
0.92
+5%
1
+9%
1.09
+9%
1.18
+8%
1.28
+8%
1.36
+6%
1.35
-1%
1.36
+1%
1.39
+2%
1.38
-1%
1.3
-6%
1.34
+3%
1.31
-2%
1.38
+5%
1.48
+7%
1.55
+5%
1.6
+3%
1.61
+1%
1.84
+14%
2.15
+17%
2.23
+4%
2.55
+14%
2.63
+3%
2.68
+2%
2.57
-4%
2.39
-7%
2.34
-2%
2.2
-6%
2.29
+4%
2.31
+1%
2.29
-1%
2.12
-7%
2.31
+9%
2.28
-1%
2.14
-6%
2.26
+6%

See Also

Summary
MEGA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEGA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEGA stock valuation using valuation multiples.
Wall Street Estimates
MEGA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEGA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 308,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.